Press Releases

Flow Cytometry Innovations Contribute to User Uptake and Market Growth

Instrumentation, Software Advances Are Driving Market

February 12, 2019

WELLESLEY, Mass., Feb. 12, 2019 – The global flow cytometry market is poised to undergo significant changes. New molecular diagnostic and monoclonal antibody tests, the introduction of small and easy-to-use laser systems and advances in IT will all contribute to market growth, according to a new report by BCC Research.

The global market for flow cytometry is valued at an estimated $4.6 billion and is expected to reach $7.3 billion in 2023 at a compound annual growth rate of 9.7% during the forecast period, according to the report “Flow Cytometry: Products, Technologies and Global Markets.”

Major players in the industry include: Beckman Coulter (Danaher Corp., DHR), Becton Dickinson & Co. (BDX), Miltenyi Biotec, Thermo Fisher Scientific Inc. (TMO), MilliporeSigma (Merck KGaA, MKKGY), Luminex Corp. (LMNX), and others.

Research Highlights:

  • North America holds the dominant market position due to innovations in instrumentation design, availability of a wide array of reagents, and the large potential for clinical research in this region.
  • Europe follows, with a market that is expected to grow by 8.2%. Europe benefits from the presence of prominent players including IntelliCyt Corp. and MilliporeSigma.
  • The increased research and clinical needs for flow cytometry in emerging countries are expected to drive growth in these markets by 12.9%. Better healthcare infrastructures are attracting higher investments from foreign companies.

“The global flow cytometry market is poised to remain among the fastest-growing segments of the life sciences and clinical diagnostics markets,” said BCC Research analyst and report author Honey Dave. “Flow cytometry offers some of the greatest potential for growth and innovation in these areas. Market restraints include the high cost of instruments, shortage of trained personnel and lack of awareness among end users.”

Software Advances Spur Flow Cytometry Use

Developments in flow cytometry software are boosting the adoption of this technique in many research areas. New software packages allow multiparameter analysis, enhanced user controls, automation and data reporting, among other features such as cloud connectivity. These allow users to gain deeper insight into cellular features.

Editors/reporters requesting analyst interviews should contact Eric Surber at press@bccresearch.com.

Flow Cytometry: Products, Technologies and Global Markets( BIO085D )
Publish Date:     

Data and analysis extracted from this press release must be accompanied by a statement identifying BCC Research LLC as the source and publisher. For media inquiries, email press@bccresearch.com or visit www.bccresearch.com/media to request access to our library of market research.